Healthcare & Life Sciences
SuppreMol GmbH
Germany
series-c-plus
series-c-plus
Stage
1
Investors
About
SuppreMol GmbH is a biotechnology company founded in 2002 as a spin-off of the Max-Planck-Institut für Biochemie. The company develops novel therapies targeting autoimmune diseases.
Explore SuppreMol GmbH's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.